Sign In
Buy BEAM
$25.52
-0.97 (-3.66%)
At Close: Jul 31, 2026
Beam Therapeutics Inc. (BEAM) Reports Q4 Loss, Tops Revenue Estimates
09:15am, Tuesday, 25'th Feb 2025
Beam Therapeutics Inc. (BEAM) came out with a quarterly loss of $1.09 per share versus the Zacks Consensus Estimate of a loss of $1.10. This compares to earnings of $1.73 per share a year ago.
Beam Therapeutics Reports Fourth Quarter and Year-End 2024 Financial Results and Reiterates Anticipated Catalysts
07:00am, Tuesday, 25'th Feb 2025
Enrollment Target for Adult Sickle Cell Disease Patients Achieved in BEACON Trial of BEAM-101; Dosing of 30 Patients and Updated Data Expected by Mid-2025 Initial Data from Phase 1/2 Trial of BEAM-302
Beam Therapeutics to Participate in Upcoming March 2025 Investor Conferences
07:00am, Monday, 24'th Feb 2025
CAMBRIDGE, Mass., Feb. 24, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that man
Wall Street Analysts See a 67.27% Upside in Beam Therapeutics (BEAM): Can the Stock Really Move This High?
10:56am, Thursday, 13'th Feb 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 67.3% in Beam Therapeutics (BEAM). While the effectiveness of this highly sought-after metric is questionable,
Is Beam Therapeutics (BEAM) Outperforming Other Medical Stocks This Year?
10:40am, Monday, 10'th Feb 2025
Here is how Beam Therapeutics Inc. (BEAM) and Aurora Cannabis Inc. (ACB) have performed compared to their sector so far this year.
Beam Therapeutics to Participate in Guggenheim SMID Cap Biotech Conference
07:00am, Thursday, 30'th Jan 2025
CAMBRIDGE, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that Joh
Wall Street Analysts Think Beam Therapeutics (BEAM) Could Surge 84.45%: Read This Before Placing a Bet
10:56am, Tuesday, 28'th Jan 2025
The average of price targets set by Wall Street analysts indicates a potential upside of 84.5% in Beam Therapeutics (BEAM). While the effectiveness of this highly sought-after metric is questionable,
Is it a Good Idea to Invest in Beam Therapeutics Stock Now?
11:40am, Friday, 24'th Jan 2025
Here, we discuss some reasons why investing in BEAM stock now may turn out to be a prudent move.
CAMBRIDGE, Mass., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced the comp
Is Beam Therapeutics (BEAM) Stock a Solid Choice Right Now?
11:41am, Monday, 13'th Jan 2025
Beam Therapeutics (BEAM) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Beam Therapeutics Announces Progress in Hematology and Genetic Disease Franchises and Outlines Key 2025 Anticipated Catalysts
07:00am, Monday, 13'th Jan 2025
More Than 40 Adult Sickle Cell Disease Patients Now Enrolled in BEACON Trial of BEAM-101; Beam Expects to Dose 30 Patients and Present Updated Data by Mid-2025
2 Stocks for Bulls This Year: Beam Therapeutics, Bloom Energy
11:30am, Friday, 10'th Jan 2025
Beam Therapeutics (BEAM) Gene editing firm Beam Therapeutics is developing its own pipeline with base editing as its foundation technology, a technique that changes a single DNA or RNA base without cu
5 Biotech Breakthrough Stocks to Watch in 2025
10:40am, Monday, 23'rd Dec 2024
After a decent first half, the drug and biotech sector saw a major downturn in the second half due to disappointing third-quarter sales and profits, guidance cuts, pipeline setbacks and the appointmen
Beam Therapeutics Appoints Sravan Emany as New CFO, Shares Up
09:25am, Monday, 09'th Dec 2024
BEAM appoints Sravan K. Emany as its new chief financial officer, effective Dec. 19.
NHP Data Showed CD117 Monoclonal Antibody (mAb) Conditioning Successfully Achieved Long-term Engraftment of Base-edited Hematopoietic Stem Cells and Induced Robust Levels of Hemoglobin F
